Drug-related catatonia in youths: real-world insights from the WHO Safety Database.

[1]  Abdallah Samr Dawood,et al.  Catatonia after COVID-19 infection: scoping review. , 2022, BJPsych bulletin.

[2]  G. Fricchione,et al.  The Incidence of Catatonia Diagnosis Among Pediatric Patients Discharged From General Hospitals in the United States: A Kids' Inpatient Database Study , 2022, Frontiers in Psychiatry.

[3]  S. Prakash,et al.  Coexistence of serotonin syndrome and neuroleptic malignant syndrome: does it exist? , 2021, BMJ Case Reports.

[4]  M. Temsah,et al.  Clinical characteristics of headache after vaccination against COVID-19 (coronavirus SARS-CoV-2) with the BNT162b2 mRNA vaccine: a multicentre observational cohort study , 2021, Brain communications.

[5]  A. Sartorius,et al.  Antipsychotic-induced catatonia and neuroleptic malignant syndrome: the dark side of the moon , 2021, Molecular Psychiatry.

[6]  G. Hasler,et al.  Clozapine withdrawal catatonia in a young schizophrenic man. , 2020, L'Encephale.

[7]  H. Saal,et al.  Case Report: Is Catatonia a Clinical Feature of the Natural Progression of NLGN2-Related Neurodevelopmental Disorder? , 2020, Journal of Autism and Developmental Disorders.

[8]  R. Heekin,et al.  First known case of catatonia due to cyclosporine A-related neurotoxicity in a pediatric patient with steroid-resistant nephrotic syndrome , 2019, BMC Psychiatry.

[9]  J. Faillie.  Case-non-case studies: Principle, methods, bias and interpretation. , 2019, Therapie.

[10]  J. Sareen,et al.  Review of withdrawal catatonia: what does this reveal about clozapine? , 2018, Translational Psychiatry.

[11]  K. Jacobson,et al.  Catatonia Under-Diagnosis in the General Hospital. , 2018, The Journal of Neuropsychiatry and Clinical Neurosciences.

[12]  D. Cohen,et al.  Catatonia in children and adolescents: New perspectives , 2017, Schizophrenia Research.

[13]  N. Ghaziuddin,et al.  Neuroleptic Malignant Syndrome/Malignant Catatonia in Child Psychiatry: Literature Review and a Case Series. , 2017, Journal of child and adolescent psychopharmacology.

[14]  M. Mazurek,et al.  Catatonia: Our current understanding of its diagnosis, treatment and pathophysiology , 2016, World journal of psychiatry.

[15]  D. Cohen,et al.  Validation of the Pediatric Catatonia Rating Scale (PCRS) , 2016, Schizophrenia Research.

[16]  M. Sahoo,et al.  Catatonia versus neuroleptic malignant syndrome: the diagnostic dilemma and treatment , 2014, Industrial psychiatry journal.

[17]  J. Bostwick,et al.  Psychiatric adverse effects of pediatric corticosteroid use. , 2014, Mayo Clinic proceedings.

[18]  M. Owen,et al.  Catatonia in DSM-5 , 2013, Schizophrenia Research.

[19]  D. Youssef,et al.  Assessment of Behavior Abnormalities of Corticosteroids in Children with Nephrotic Syndrome , 2013, ISRN psychiatry.

[20]  D. Dhossche,et al.  Catatonia is hidden in plain sight among different pediatric disorders: a review article. , 2010, Pediatric neurology.

[21]  A. Francis.  Catatonia: Diagnosis, Classification, and Treatment , 2010, Current psychiatry reports.

[22]  Jessica E Daniels.  Catatonia: clinical aspects and neurobiological correlates. , 2009, The Journal of neuropsychiatry and clinical neurosciences.

[23]  D. Cohen,et al.  Association of adolescent catatonia with increased mortality and morbidity: Evidence from a prospective follow-up study , 2009, Schizophrenia Research.

[24]  A. Bate,et al.  Quantitative signal detection using spontaneous ADR reporting , 2009, Pharmacoepidemiology and drug safety.

[25]  P. Desarkar,et al.  Lithium toxicity presenting as catatonia in an adolescent girl. , 2007, Journal of clinical psychopharmacology.

[26]  D. Cohen,et al.  Clinical relevance of chronic catatonic schizophrenia in children and adolescents: Evidence from a prospective naturalistic study , 2005, Schizophrenia Research.

[27]  V. Sinha,et al.  Incidence of Catatonia in Children and Adolescents in a Paediatric Psychiatric Clinic , 2003, The Australian and New Zealand journal of psychiatry.

[28]  K. Takaoka,et al.  Catatonia in childhood and adolescence , 2003, Psychiatry and clinical neurosciences.

[29]  A. Bate,et al.  A Bayesian neural network method for adverse drug reaction signal generation , 1998, European Journal of Clinical Pharmacology.

[30]  J. Hersh,et al.  A male with fetal valproate syndrome and autism , 1997, Developmental medicine and child neurology.

[31]  J. D. Dickerman,et al.  Steroid-associated catatonia: report of a case. , 1979, Pediatrics.

[32]  L. Hazell,et al.  Under-Reporting of Adverse Drug Reactions , 2006, Drug safety.

[33]  Jeffrey K Aronson,et al.  Clarification of Terminology in Drug Safety , 2005, Drug safety.